Environmental Risk Assessment of Paroxetine
Paroxetine hydrochloride hemihydrate (the active ingredient in Paxil) is a pharmaceutical compound used for the treatment of depression, social anxiety disorder, obsessive compulsive disorder, panic disorder, and generalized anxiety disorder. Paroxetine (PA) is extensively metabolized in humans, wit...
Gespeichert in:
Veröffentlicht in: | Environmental science & technology 2004-06, Vol.38 (12), p.3351-3359 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 3359 |
---|---|
container_issue | 12 |
container_start_page | 3351 |
container_title | Environmental science & technology |
container_volume | 38 |
creator | Cunningham, Virginia L Constable, David J. C Hannah, Robert E |
description | Paroxetine hydrochloride hemihydrate (the active ingredient in Paxil) is a pharmaceutical compound used for the treatment of depression, social anxiety disorder, obsessive compulsive disorder, panic disorder, and generalized anxiety disorder. Paroxetine (PA) is extensively metabolized in humans, with about 97% of the parent compound being excreted as metabolites through the urine and feces of patients. Therefore PA and metabolites have the potential to be discharged into wastewater treatment systems after therapeutic use. PA and its major human metabolite (PM) were investigated using studies designed to describe physical/chemical characteristics and determine their fate and effects in the aquatic environment. A significant portion of the PM entering a wastewater treatment plant would be expected to biodegrade given the higher activated sludge solids concentrations present in a typical wastewater treatment plant. The potential for direct photolysis of PM is also possible based on photolysis results for PA itself. These results provide strong support for expecting that PA and PM residuals will not persist in the aquatic environment after discharge from a wastewater treatment facility. This conclusion is also supported by the results of a USGS monitoring study, where no PM was detected in any of the samples at the 260 ng/L reporting limit. The results presented here also demonstrate the importance of understanding the human metabolism of a pharmaceutical so that the appropriate molecule(s) is used for fate and effects studies. In addition to the PA fate studies, PM was investigated using studies designed to determine potential environmental effects and a predicted no effect level (PNEC). The average measured activated sludge respiration inhibition value (EC50) for PM was 82 mg/L. The measured Microtox EC50 value was 33.0 mg/L, while the Daphnia magna EC50 value was 35.0 mg/L. The PNEC for PM was calculated to be 35.0 μg/L. Fate data were then used in a new watershed-based environmental risk assessment model, PhATE, to predict environmental concentrations (PECs). Comparison of the calculated PECs with the PNEC allows an assessment of potential environmental risk. Within the 1−99% of stream segments in the PhATE model, PEC values ranged from 0.003 to 100 ng/L. The risk assessment PEC/PNEC ratios ranged from ∼3 × 10-8 to ∼3 × 10-3, indicating a wide margin of safety, since a PEC/PNEC ratio < 1 is generally considered to represent a low risk to the environment. I |
doi_str_mv | 10.1021/es035119x |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_20833899</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>690790871</sourcerecordid><originalsourceid>FETCH-LOGICAL-a406t-1a7e324ddc926e196417285e835164e6e67144626d34bdefc47f0bc1465473133</originalsourceid><addsrcrecordid>eNplkNtKw0AURQdRbK0--ANSBAWR6NwneSzFGwoWreDbME1OIG2a1DmJ1L93SksVfRo4s1jsvQk5ZvSKUc6uAalQjCXLHdJlitNIxYrtki6lTESJ0O8dcoA4pZRyQeN90gmQpkKoLrm8qT4LX1dzqBpX9l8KnPUHiIC4uvTrvD9yvl5CU1RwSPZyVyIcbd4eebu9GQ_vo6fnu4fh4ClykuomYs6A4DLL0oRrYImWzPBYQRwyagkatGFSaq4zIScZ5Kk0OZ2kTGoljWBC9Mj52rvw9UcL2Nh5gSmUpaugbtFyGgsRJ0kAT_-A07r1VchmQ9FgUkoG6GINpb5G9JDbhS_mzn9ZRu1qPrudL7AnG2E7mUP2Q272CsDZBnCYujL3rkoL_MXFJrhWFaI1V2ADy-2_8zOrjTDKjkevdvjIh_dmpELYrdel-FPif8BvKp6PKQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>230133554</pqid></control><display><type>article</type><title>Environmental Risk Assessment of Paroxetine</title><source>ACS Publications</source><source>MEDLINE</source><creator>Cunningham, Virginia L ; Constable, David J. C ; Hannah, Robert E</creator><creatorcontrib>Cunningham, Virginia L ; Constable, David J. C ; Hannah, Robert E</creatorcontrib><description>Paroxetine hydrochloride hemihydrate (the active ingredient in Paxil) is a pharmaceutical compound used for the treatment of depression, social anxiety disorder, obsessive compulsive disorder, panic disorder, and generalized anxiety disorder. Paroxetine (PA) is extensively metabolized in humans, with about 97% of the parent compound being excreted as metabolites through the urine and feces of patients. Therefore PA and metabolites have the potential to be discharged into wastewater treatment systems after therapeutic use. PA and its major human metabolite (PM) were investigated using studies designed to describe physical/chemical characteristics and determine their fate and effects in the aquatic environment. A significant portion of the PM entering a wastewater treatment plant would be expected to biodegrade given the higher activated sludge solids concentrations present in a typical wastewater treatment plant. The potential for direct photolysis of PM is also possible based on photolysis results for PA itself. These results provide strong support for expecting that PA and PM residuals will not persist in the aquatic environment after discharge from a wastewater treatment facility. This conclusion is also supported by the results of a USGS monitoring study, where no PM was detected in any of the samples at the 260 ng/L reporting limit. The results presented here also demonstrate the importance of understanding the human metabolism of a pharmaceutical so that the appropriate molecule(s) is used for fate and effects studies. In addition to the PA fate studies, PM was investigated using studies designed to determine potential environmental effects and a predicted no effect level (PNEC). The average measured activated sludge respiration inhibition value (EC50) for PM was 82 mg/L. The measured Microtox EC50 value was 33.0 mg/L, while the Daphnia magna EC50 value was 35.0 mg/L. The PNEC for PM was calculated to be 35.0 μg/L. Fate data were then used in a new watershed-based environmental risk assessment model, PhATE, to predict environmental concentrations (PECs). Comparison of the calculated PECs with the PNEC allows an assessment of potential environmental risk. Within the 1−99% of stream segments in the PhATE model, PEC values ranged from 0.003 to 100 ng/L. The risk assessment PEC/PNEC ratios ranged from ∼3 × 10-8 to ∼3 × 10-3, indicating a wide margin of safety, since a PEC/PNEC ratio < 1 is generally considered to represent a low risk to the environment. In addition, Microtox studies carried out on PM biodegradation byproducts indicated no detectable residual toxicity. Any compounds in the environment as a result of the biodegradation of PM should be innocuous polar byproducts that should not exert any toxic effects.</description><identifier>ISSN: 0013-936X</identifier><identifier>EISSN: 1520-5851</identifier><identifier>DOI: 10.1021/es035119x</identifier><identifier>PMID: 15260335</identifier><identifier>CODEN: ESTHAG</identifier><language>eng</language><publisher>Washington, DC: American Chemical Society</publisher><subject>Analysis ; Animal, plant and microbial ecology ; Animals ; Anxiety disorders ; Applied ecology ; Applied sciences ; Biodegradation ; Biodegradation, Environmental ; Biological and medical sciences ; Daphnia ; Daphnia magna ; Ecotoxicology, biological effects of pollution ; Environmental impact ; Exact sciences and technology ; Fresh water environment ; Fundamental and applied biological sciences. Psychology ; Global environmental pollution ; Lethal Dose 50 ; Metabolites ; Paroxetine - metabolism ; Paroxetine - toxicity ; Pharmaceuticals ; Photochemistry ; Pollution ; Risk Assessment ; Serotonin Uptake Inhibitors - metabolism ; Serotonin Uptake Inhibitors - toxicity ; Sewage - microbiology ; Vibrio ; Waste Disposal, Fluid - methods ; Water treatment ; Water treatment plants</subject><ispartof>Environmental science & technology, 2004-06, Vol.38 (12), p.3351-3359</ispartof><rights>Copyright © 2004 American Chemical Society</rights><rights>2004 INIST-CNRS</rights><rights>Copyright American Chemical Society Jun 15, 2004</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a406t-1a7e324ddc926e196417285e835164e6e67144626d34bdefc47f0bc1465473133</citedby><cites>FETCH-LOGICAL-a406t-1a7e324ddc926e196417285e835164e6e67144626d34bdefc47f0bc1465473133</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/es035119x$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/es035119x$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,776,780,2752,27053,27901,27902,56713,56763</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=15870353$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15260335$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cunningham, Virginia L</creatorcontrib><creatorcontrib>Constable, David J. C</creatorcontrib><creatorcontrib>Hannah, Robert E</creatorcontrib><title>Environmental Risk Assessment of Paroxetine</title><title>Environmental science & technology</title><addtitle>Environ. Sci. Technol</addtitle><description>Paroxetine hydrochloride hemihydrate (the active ingredient in Paxil) is a pharmaceutical compound used for the treatment of depression, social anxiety disorder, obsessive compulsive disorder, panic disorder, and generalized anxiety disorder. Paroxetine (PA) is extensively metabolized in humans, with about 97% of the parent compound being excreted as metabolites through the urine and feces of patients. Therefore PA and metabolites have the potential to be discharged into wastewater treatment systems after therapeutic use. PA and its major human metabolite (PM) were investigated using studies designed to describe physical/chemical characteristics and determine their fate and effects in the aquatic environment. A significant portion of the PM entering a wastewater treatment plant would be expected to biodegrade given the higher activated sludge solids concentrations present in a typical wastewater treatment plant. The potential for direct photolysis of PM is also possible based on photolysis results for PA itself. These results provide strong support for expecting that PA and PM residuals will not persist in the aquatic environment after discharge from a wastewater treatment facility. This conclusion is also supported by the results of a USGS monitoring study, where no PM was detected in any of the samples at the 260 ng/L reporting limit. The results presented here also demonstrate the importance of understanding the human metabolism of a pharmaceutical so that the appropriate molecule(s) is used for fate and effects studies. In addition to the PA fate studies, PM was investigated using studies designed to determine potential environmental effects and a predicted no effect level (PNEC). The average measured activated sludge respiration inhibition value (EC50) for PM was 82 mg/L. The measured Microtox EC50 value was 33.0 mg/L, while the Daphnia magna EC50 value was 35.0 mg/L. The PNEC for PM was calculated to be 35.0 μg/L. Fate data were then used in a new watershed-based environmental risk assessment model, PhATE, to predict environmental concentrations (PECs). Comparison of the calculated PECs with the PNEC allows an assessment of potential environmental risk. Within the 1−99% of stream segments in the PhATE model, PEC values ranged from 0.003 to 100 ng/L. The risk assessment PEC/PNEC ratios ranged from ∼3 × 10-8 to ∼3 × 10-3, indicating a wide margin of safety, since a PEC/PNEC ratio < 1 is generally considered to represent a low risk to the environment. In addition, Microtox studies carried out on PM biodegradation byproducts indicated no detectable residual toxicity. Any compounds in the environment as a result of the biodegradation of PM should be innocuous polar byproducts that should not exert any toxic effects.</description><subject>Analysis</subject><subject>Animal, plant and microbial ecology</subject><subject>Animals</subject><subject>Anxiety disorders</subject><subject>Applied ecology</subject><subject>Applied sciences</subject><subject>Biodegradation</subject><subject>Biodegradation, Environmental</subject><subject>Biological and medical sciences</subject><subject>Daphnia</subject><subject>Daphnia magna</subject><subject>Ecotoxicology, biological effects of pollution</subject><subject>Environmental impact</subject><subject>Exact sciences and technology</subject><subject>Fresh water environment</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Global environmental pollution</subject><subject>Lethal Dose 50</subject><subject>Metabolites</subject><subject>Paroxetine - metabolism</subject><subject>Paroxetine - toxicity</subject><subject>Pharmaceuticals</subject><subject>Photochemistry</subject><subject>Pollution</subject><subject>Risk Assessment</subject><subject>Serotonin Uptake Inhibitors - metabolism</subject><subject>Serotonin Uptake Inhibitors - toxicity</subject><subject>Sewage - microbiology</subject><subject>Vibrio</subject><subject>Waste Disposal, Fluid - methods</subject><subject>Water treatment</subject><subject>Water treatment plants</subject><issn>0013-936X</issn><issn>1520-5851</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNplkNtKw0AURQdRbK0--ANSBAWR6NwneSzFGwoWreDbME1OIG2a1DmJ1L93SksVfRo4s1jsvQk5ZvSKUc6uAalQjCXLHdJlitNIxYrtki6lTESJ0O8dcoA4pZRyQeN90gmQpkKoLrm8qT4LX1dzqBpX9l8KnPUHiIC4uvTrvD9yvl5CU1RwSPZyVyIcbd4eebu9GQ_vo6fnu4fh4ClykuomYs6A4DLL0oRrYImWzPBYQRwyagkatGFSaq4zIScZ5Kk0OZ2kTGoljWBC9Mj52rvw9UcL2Nh5gSmUpaugbtFyGgsRJ0kAT_-A07r1VchmQ9FgUkoG6GINpb5G9JDbhS_mzn9ZRu1qPrudL7AnG2E7mUP2Q272CsDZBnCYujL3rkoL_MXFJrhWFaI1V2ADy-2_8zOrjTDKjkevdvjIh_dmpELYrdel-FPif8BvKp6PKQ</recordid><startdate>20040615</startdate><enddate>20040615</enddate><creator>Cunningham, Virginia L</creator><creator>Constable, David J. C</creator><creator>Hannah, Robert E</creator><general>American Chemical Society</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7ST</scope><scope>7T7</scope><scope>7U7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>P64</scope><scope>SOI</scope><scope>7TV</scope><scope>7U1</scope><scope>7U2</scope></search><sort><creationdate>20040615</creationdate><title>Environmental Risk Assessment of Paroxetine</title><author>Cunningham, Virginia L ; Constable, David J. C ; Hannah, Robert E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a406t-1a7e324ddc926e196417285e835164e6e67144626d34bdefc47f0bc1465473133</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Analysis</topic><topic>Animal, plant and microbial ecology</topic><topic>Animals</topic><topic>Anxiety disorders</topic><topic>Applied ecology</topic><topic>Applied sciences</topic><topic>Biodegradation</topic><topic>Biodegradation, Environmental</topic><topic>Biological and medical sciences</topic><topic>Daphnia</topic><topic>Daphnia magna</topic><topic>Ecotoxicology, biological effects of pollution</topic><topic>Environmental impact</topic><topic>Exact sciences and technology</topic><topic>Fresh water environment</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Global environmental pollution</topic><topic>Lethal Dose 50</topic><topic>Metabolites</topic><topic>Paroxetine - metabolism</topic><topic>Paroxetine - toxicity</topic><topic>Pharmaceuticals</topic><topic>Photochemistry</topic><topic>Pollution</topic><topic>Risk Assessment</topic><topic>Serotonin Uptake Inhibitors - metabolism</topic><topic>Serotonin Uptake Inhibitors - toxicity</topic><topic>Sewage - microbiology</topic><topic>Vibrio</topic><topic>Waste Disposal, Fluid - methods</topic><topic>Water treatment</topic><topic>Water treatment plants</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cunningham, Virginia L</creatorcontrib><creatorcontrib>Constable, David J. C</creatorcontrib><creatorcontrib>Hannah, Robert E</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Environment Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Toxicology Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environment Abstracts</collection><collection>Pollution Abstracts</collection><collection>Risk Abstracts</collection><collection>Safety Science and Risk</collection><jtitle>Environmental science & technology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cunningham, Virginia L</au><au>Constable, David J. C</au><au>Hannah, Robert E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Environmental Risk Assessment of Paroxetine</atitle><jtitle>Environmental science & technology</jtitle><addtitle>Environ. Sci. Technol</addtitle><date>2004-06-15</date><risdate>2004</risdate><volume>38</volume><issue>12</issue><spage>3351</spage><epage>3359</epage><pages>3351-3359</pages><issn>0013-936X</issn><eissn>1520-5851</eissn><coden>ESTHAG</coden><abstract>Paroxetine hydrochloride hemihydrate (the active ingredient in Paxil) is a pharmaceutical compound used for the treatment of depression, social anxiety disorder, obsessive compulsive disorder, panic disorder, and generalized anxiety disorder. Paroxetine (PA) is extensively metabolized in humans, with about 97% of the parent compound being excreted as metabolites through the urine and feces of patients. Therefore PA and metabolites have the potential to be discharged into wastewater treatment systems after therapeutic use. PA and its major human metabolite (PM) were investigated using studies designed to describe physical/chemical characteristics and determine their fate and effects in the aquatic environment. A significant portion of the PM entering a wastewater treatment plant would be expected to biodegrade given the higher activated sludge solids concentrations present in a typical wastewater treatment plant. The potential for direct photolysis of PM is also possible based on photolysis results for PA itself. These results provide strong support for expecting that PA and PM residuals will not persist in the aquatic environment after discharge from a wastewater treatment facility. This conclusion is also supported by the results of a USGS monitoring study, where no PM was detected in any of the samples at the 260 ng/L reporting limit. The results presented here also demonstrate the importance of understanding the human metabolism of a pharmaceutical so that the appropriate molecule(s) is used for fate and effects studies. In addition to the PA fate studies, PM was investigated using studies designed to determine potential environmental effects and a predicted no effect level (PNEC). The average measured activated sludge respiration inhibition value (EC50) for PM was 82 mg/L. The measured Microtox EC50 value was 33.0 mg/L, while the Daphnia magna EC50 value was 35.0 mg/L. The PNEC for PM was calculated to be 35.0 μg/L. Fate data were then used in a new watershed-based environmental risk assessment model, PhATE, to predict environmental concentrations (PECs). Comparison of the calculated PECs with the PNEC allows an assessment of potential environmental risk. Within the 1−99% of stream segments in the PhATE model, PEC values ranged from 0.003 to 100 ng/L. The risk assessment PEC/PNEC ratios ranged from ∼3 × 10-8 to ∼3 × 10-3, indicating a wide margin of safety, since a PEC/PNEC ratio < 1 is generally considered to represent a low risk to the environment. In addition, Microtox studies carried out on PM biodegradation byproducts indicated no detectable residual toxicity. Any compounds in the environment as a result of the biodegradation of PM should be innocuous polar byproducts that should not exert any toxic effects.</abstract><cop>Washington, DC</cop><pub>American Chemical Society</pub><pmid>15260335</pmid><doi>10.1021/es035119x</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0013-936X |
ispartof | Environmental science & technology, 2004-06, Vol.38 (12), p.3351-3359 |
issn | 0013-936X 1520-5851 |
language | eng |
recordid | cdi_proquest_miscellaneous_20833899 |
source | ACS Publications; MEDLINE |
subjects | Analysis Animal, plant and microbial ecology Animals Anxiety disorders Applied ecology Applied sciences Biodegradation Biodegradation, Environmental Biological and medical sciences Daphnia Daphnia magna Ecotoxicology, biological effects of pollution Environmental impact Exact sciences and technology Fresh water environment Fundamental and applied biological sciences. Psychology Global environmental pollution Lethal Dose 50 Metabolites Paroxetine - metabolism Paroxetine - toxicity Pharmaceuticals Photochemistry Pollution Risk Assessment Serotonin Uptake Inhibitors - metabolism Serotonin Uptake Inhibitors - toxicity Sewage - microbiology Vibrio Waste Disposal, Fluid - methods Water treatment Water treatment plants |
title | Environmental Risk Assessment of Paroxetine |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T19%3A13%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Environmental%20Risk%20Assessment%20of%20Paroxetine&rft.jtitle=Environmental%20science%20&%20technology&rft.au=Cunningham,%20Virginia%20L&rft.date=2004-06-15&rft.volume=38&rft.issue=12&rft.spage=3351&rft.epage=3359&rft.pages=3351-3359&rft.issn=0013-936X&rft.eissn=1520-5851&rft.coden=ESTHAG&rft_id=info:doi/10.1021/es035119x&rft_dat=%3Cproquest_cross%3E690790871%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=230133554&rft_id=info:pmid/15260335&rfr_iscdi=true |